Building Bridges — The FBI, Academia, Industry and the Challenges of Synbio
14 August 2009
Foley Partner and chair of the Health Care Industry Team Mark Waxman authored an article titled “Building Bridges—The FBI, Academia, Industry and the Challenges of Synbio” in the August 14, 2009 issue of BNA’s Life Sciences Law & Industry Report.
Reproduced with permission from Life Sciences Law & Industry Report, 3 LSLR 849 (Aug. 14, 2009). Copyright 2009 by The Bureau of National Affairs, Inc. (800-372-1033) http://www.bna.com.
Related Insights
18 February 2025
Labor & Employment Law Perspectives
Noncompete Bans – Next Up: Ohio
This month, Ohio joined the list of states with pending legislation to ban noncompetes. With the FTC noncompete ban blocked on a nationwide basis last year, Ohio lawmakers introduced a bill on February 5, 2025, that would ban noncompete contracts as a condition of employment in the state.
18 February 2025
DEA Delays Final Buprenorphine Rule
The Department of Health and Human Services and the Drug Enforcement Administration have delayed the effective date of the final rule regarding telemedicine prescribing of buprenorphine to March 21, 2025, and have requested public comments on the rule.
17 February 2025
Foley Viewpoints
6 Steps to Manage Tariff Risks in a Trade War
As Trump seeks to raise U.S. tariffs (which currently tend to be among the lowest worldwide), manufacturers, distributors, retailers, and other companies that frequently import must determine the best strategy to deal with the resulting uncertainties.